Is Beta recalled?
123 FDA recalls mention Beta. The most recent are listed below.
Recalls are matched by product description. A recall usually affects specific lots, not every package of Beta.
Class II · Moderate risk Terminated Mar 15, 2022
Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.
Class II · Moderate risk Terminated Mar 15, 2022
Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.
Class II · Moderate risk Terminated Mar 15, 2022
Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.
Class II · Moderate risk Terminated Mar 15, 2022
Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.
Class II · Moderate risk Terminated Mar 15, 2022
Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.
Class II · Moderate risk Terminated Mar 15, 2022
Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.
Class II · Moderate risk Terminated Mar 15, 2022
Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.
Class III · Low risk Terminated Feb 25, 2022
Reason Failed Content Uniformity Specifications: Out-of-specification result for the Betamethasone Dipropionate assay of a stability sample
Class II · Moderate risk Ongoing Jan 14, 2022
Reason CGMP Deviation: Difficulty dispensing/does not dispense or dispensing liquid instead of foam.
Class II · Moderate risk Terminated Jan 10, 2022
Reason CGMP Deviations
Class I · High risk Terminated Dec 15, 2021
Reason Microbial Contamination of Non-Sterile Products: presence of R. Pickettii bacteria
Class II · Moderate risk Terminated Dec 6, 2021
Reason Lack of Assurance of Sterility
Class II · Moderate risk Terminated Oct 4, 2021
Reason Microbial Contamination of Sterile Products: Confirmed sterility failure identified during stability testing at the 12-month time point.
Class II · Moderate risk Terminated Aug 26, 2021
Reason Subpotent Drug
Class II · Moderate risk Terminated Aug 23, 2021
Reason Failed Stability Specifications: lot did not meet specification for the Active Pharmaceutical Ingredient (API) particle test, which was determined…
Class II · Moderate risk Terminated Aug 13, 2021
Reason Failed impurities/degradation specification: Out of Specification for an unknown impurity observed in topical product.
Class II · Moderate risk Terminated Apr 12, 2021
Reason Defective container; syringe content migrating past the seal of the plunger may cause a lack of assurance of sterility
Class III · Low risk Terminated Feb 2, 2021
Reason Failed Impurities/ Degradation Specifications - OOS for know impurity Betamethasone 17- propionate.
Class III · Low risk Terminated Feb 2, 2021
Reason Failed Impurities/ Degradation Specifications - OOS for know impurity Betamethasone 17- propionate.
Class III · Low risk Terminated Feb 2, 2021
Reason Failed Impurities/ Degradation Specifications - OOS for know impurity Betamethasone 17- propionate.
Class II · Moderate risk Terminated Dec 17, 2020
Reason Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit
Class II · Moderate risk Ongoing Nov 30, 2020
Reason Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.
Class III · Low risk Terminated Nov 5, 2020
Reason Superpotent and Subpotent; low and high assay results
Class II · Moderate risk Terminated Oct 9, 2020
Reason GMP Deviations
Class III · Low risk Terminated Jul 24, 2020
Reason Failed Content Uniformity: bulk lot used to make these two lots was found to have failed content uniformity.